On Air Now

Now Playing

The Paradigm Shift Album Cover Hater by Korn
Our Playlist »

Listen

Listen Live Now » 106.1 FM Lansing, Michigan

Weather

Current Conditions(Holt,MI 48842)

More Weather »
57° Feels Like: 57°
Wind: NNW 8 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Scattered Thunderstorms 62°

Tonight

Clouds Early/Clearing Late 43°

Tomorrow

Sunny 63°

Alerts

India's Cipla launches copy of GSK's top asthma drug in Germany, Sweden

MUMBAI (Reuters) - India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product.

Cipla's drug will be marketed under the name Serrofloin in Germany and Salmeterol/Fluticasone Cipla in Sweden, the Mumbai-based company said in a statement on Monday.

In December, Denmark became the first European country to approve for sale a generic version of GlaxoSmithKline's $8 billion-a-year Advair, and analysts have been expecting more such approvals.

Making copies of inhaled drugs such as Advair is a challenge because of the complexity of making a device that effectively delivers the medicine directly into the lungs.

(Reporting by Zeba Siddiqui in Mumbai; Editing by Prateek Chatterjee)

Comments